Additionally, individuals with autoimmune or gastrointestinal disorders, such as pernicious anemia, celiac, or Crohns disease, are more likely to be at risk of deficiency
No dosing or regimen recommendations are provided or implied for human or veterinary use
Results demonstrated that AOD-9604 displayed a very good safety and tolerability profile indistinguishable from placebo. Critically, the peptide produced no clinically significant alterations in IGF-1 levels, no glucose intolerance or insulin resistance, and no anti-AOD9604 antibodies in any participant
2 Grip Strength and Exercise Endurance in Aged Mice Dimet-Wiley et al., Scientific Reports (2024) This study compared 5-Amino-1MQ treatment, voluntary wheel-running exercise (PoWeR), and combined treatment in aged C57BL/6J mice